Question 1

Does Renaissance Technologies own BRNS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Renaissance Technologies holds 25,000 shares of BRNS (Barinthus Biotherapeutics PL), worth $16,500.

Question 2

How many shares of BRNS does Renaissance Technologies own?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies holds 25,000 shares of BRNS (Barinthus Biotherapeutics PL).

Question 3

What is Renaissance Technologies' BRNS position worth?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies' BRNS position is worth $16,500.

Question 4

Is Renaissance Technologies buying or selling BRNS?

Accepted Answer

In Q2 2026, Renaissance Technologies reduced its BRNS position by 126,000 shares (-83.4%).

Question 5

When did Renaissance Technologies first buy BRNS?

Accepted Answer

Renaissance Technologies first reported BRNS in its Q1 2023 13F and has listed it in 14 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	25,000	-83.4%	$16,500	0.0%	$0.66	0
2026-Q1	Increased	151,000	+5.5%	$85,919	0.0%	$0.60	23
2025-Q4	Increased	143,100	+115.8%	$100,184	0.0%	$0.68	35
2025-Q3	Increased	66,300	+82.6%	$82,875	0.0%	$1.48	33
2025-Q2	Increased	36,300	+1.7%	$33,763	0.0%	$0.92	14
2025-Q1	Increased	35,700	+1.7%	$34,725	0.0%	$1.05	20
2024-Q4	Increased	35,100	+25.8%	$42,401	0.0%	$1.10	25
2024-Q3	Increased	27,900	+11.2%	$33,201	0.0%	$1.18	15

BRNSShowing 8 of 14 quarters

BRNS
Showing 8 of 14 quarters